Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia.
- DOI
- 10.1177/17534666261471304
- Published
- 2026 Jan-Dec
- Container
- Therapeutic advances in respiratory disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/17534666261471304,
title = {Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia.},
author = {Lai K and Sun D and Dai R and Xu X and Zhao J and Wu T and Ho CN and Werkström V and Cohen D and Necander S and Zhong N},
year = {2026},
journal = {Therapeutic advances in respiratory disease},
doi = {10.1177/17534666261471304},
url = {https://doi.org/10.1177/17534666261471304}
}RIS
TY - JOUR TI - Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia. AU - Lai K AU - Sun D AU - Dai R AU - Xu X AU - Zhao J AU - Wu T AU - Ho CN AU - Werkström V AU - Cohen D AU - Necander S AU - Zhong N PY - 2026 JO - Therapeutic advances in respiratory disease DO - 10.1177/17534666261471304 UR - https://doi.org/10.1177/17534666261471304 ER -
APA
K, L., D, S., R, D., X, X., J, Z., T, W., CN, H., V, W., D, C., S, N., & N, Z. (2026). Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia.. Therapeutic advances in respiratory disease. https://doi.org/10.1177/17534666261471304
Source records
- pubmed · retrieved 2026-09-25T07:52:26.478Z